Search by Drug Name or NDC

NDC 72789-0184-90 Tadalafil 10 mg/1 Details

Tadalafil 10 mg/1

Tadalafil is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is TADALAFIL.

MedlinePlus Drug Summary

Tadalafil (Cialis) is used to treat erectile dysfunction (ED, impotence; inability to get or keep an erection), and the symptoms of benign prostatic hyperplasia (BPH; an enlarged prostate) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency in adult men. Tadalafil (Adcirca) is used to improve the ability to exercise in people with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Tadalafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works to treat erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Tadalafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow more easily. If you are taking tadalafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Tadalafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 72789-0184-90
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tadalafil

Product Information

NDC	72789-0184
Product ID	72789-184_030befb3-9867-57dc-e063-6394a90a6027
Associated GPIs	40304080000310
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Tadalafil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tadalafil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	TADALAFIL
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA209654
Listing Certified Through	2024-12-31

Package

NDC 72789-0184-90 (72789018490)

Pricing Information	N/A
NDC Package Code	72789-184-90
Billing NDC	72789018490
Package	90 TABLET in 1 BOTTLE, PLASTIC (72789-184-90)
Marketing Start Date	2021-08-17
NDC Exclude Flag	N